US 8791074
Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
granted A61KA61K38/00A61K47/665
Quick answer
US patent 8791074 (Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/00, A61K47/665, A61P, A61P35/00